JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB49900

HRP Anti-beta Actin antibody [AC-15] - Loading Control

5

(10 Reviews)

|

(592 Publications)

Anti-beta Actin antibody [AC-15] - HRP conjugated (ab49900) is a mouse monoclonal antibody detecting beta Actin in Western Blot. Suitable for African green monkey, Cow, Dog, Hamster, Human, Mouse, Rat.

- Over 450 publications
- Trusted since 2007

View Alternative Names

Beta-actin, ACTB

6 Images
Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)
  • WB

Supplier Data

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)

All lanes:

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (ab49900) at 1/50000 dilution

Lane 1:

A549 Lysate

Lane 2:

HeLa Lysate

Lane 3:

3T3 Lysate

Lane 4:

NRK Lysate

Lane 5:

MDCK Lysate

Lane 6:

MDBK Lysate

Lane 7:

BHK Lysate

Lane 8:

COS7 Lysate

Lane 9:

CFB Lysate

Predicted band size: 41 kDa

true

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)
  • WB

AbReview17973****

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)

Blocking Step : 5% Milk for 1 hour at 22°C.

All lanes:

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (ab49900) at 1/25000 dilution

All lanes:

Whole cell lysate of Human acute monocytic leukemia THP-1. at 10 µg

Predicted band size: 41 kDa

true

This image is courtesy of an anonymous Abreview

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)
  • WB

PubMed

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)

Proteins were loaded onto a 10% SDS-polyacrylamide gel. After gel electrophoresis, blots were subsequently probed with primary antibodies anti- IL-6 at 1∶1000 (ab6672), anti- IL-17 at 1∶3000, anti-TGF-β at 1∶1000 (ab66043). For detection, horseradish peroxidase-conjugated secondary anti-rabbit antibody was used followed by enhanced chemiluminescence development.

Normalization of results was ensured by running parallel western blots with β-actin antibody at 1∶25,000 (ab49900). The optical density was quantified using an image densitometer. The data are presented as a percentage of target protein relative to β-actin. A value of p<0.05 is considered significant.

All lanes:

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (ab49900)

Predicted band size: 41 kDa

true

Image from PLoS One. 2010 Aug 25;5(8):e12400. Fig 8, doi: 10.1371/journal.pone.0012400. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)
  • WB

CiteAb

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)

Western Blotting using HRP Anti-beta Actin antibody [AC-15]HRP Anti-beta Actin antibody [AC-15], ab49900. Publication image from Harris, A. L. et al., 2014, Mol Cancer, 24517586. Legend direct from paper.

Hypoxia regulated microRNAs in MCF-7 cells. microRNA sequencing data generated from a hypoxia time course in MCF-7 (16, 32 and 48 h at 1% Oxygen) was analysed and the overlap between the microRNAs found significantly up- or down-regulated at each time point compared to normoxia control (adj.p-val <0.05) has been represented in Venn diagrams (A). The levels of HIF-1α and HIF-2α were measured by immunoblotting across the hypoxia time course (H16h, H32h, H48h) and normoxia (N), with beta-actin used as a control (B). The down-regulation of miR-4521, miR-145-3p and miR-222-5p in hypoxia was validated by qPCR (C). Fold-changes (in linear scale) obtained for each microRNA at each time point relative to normoxia control are represented in boxplots (*significant fold-change compared to normoxia after ANOVA followed by pairwise t-test, adj.p-val ≤ 0.05). The expression of miR-145-5p and miR-222-3p was also assessed by qPCR, confirming a different pattern of expression as compared to their counterpart strands.

false

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)
  • WB

CiteAb

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)

Western Blotting using HRP Anti-beta Actin antibody [AC-15]HRP Anti-beta Actin antibody [AC-15], ab49900. Publication image from Peshkova, I. O. et al., 2019, Nat Commun, 31695038. Legend direct from paper.

Elevated expression of p53 and p21 in IL-27R-deficient HSPCs. a Scheme of experiment. b Lin− HSPCs isolated from WD-fed Apoe−/−Il27ra+/− (n = 4) and Apoe−/−Il27ra−/− (n = 4) mice infused with PBS or Apoe−/−Il27ra+/− (n = 5) and Apoe−/−Il27ra−/− (n = 4) mice infused with Ang II for 4 weeks were lysed and subjected to western blotting with p21, p53, and β-actin antibody. Each lane corresponds to individual mouse. c Quantification of WB analysis for p21 and p53, normalized to β-actin. d Scheme of experiment. e WB on Lin− HSPCs from naive Apoe−/−Il27ra+/− mice (n = 4) stimulated in vitro with Ang II, IL-27, or both for 24 h. f Quantification of WB analysis for p21. g Scheme of experiment. h Lin− HSPCs from BM of Apoe−/− (n = 4), Apoe−/−Il27ra−/− (n = 4), or Apoe−/−Il27ra−/−Trp53d/d (n = 5) mice were sorted and plated in M3434 media under myeloid conditions with or without Ang II. GM colony formation was accessed on day 6. Data are mean ± SEM from two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.005, unpaired Student’s t-test (two-tailed). i Scheme describing the role of IL-27R signaling in regulation of Ang II-induced myelopoiesis and AAA. Elevation of Ang II in AAA provides a stimulus for the activation of “stress” myelopoiesis via regulation of gene expression controlling proliferation and differentiation in IL-27R-sufficient LT-HSCs. Lack of IL-27R signaling renders Ang II-primed cells unable to overcome quiescence state and significantly reduces proliferation of progenitors and myeloid cell bone marrow output, therefore reducing cell accumulation in AAA lesions and AAA progression

false

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)
  • WB

CiteAb

Western blot - HRP Anti-beta Actin antibody [AC-15] - Loading Control (AB49900)

Western Blotting using HRP Anti-beta Actin antibody [AC-15]HRP Anti-beta Actin antibody [AC-15], ab49900. Publication image from Peshkova, I. O. et al., 2019, Nat Commun, 31695038. Legend direct from paper.

Elevated expression of p53 and p21 in IL-27R-deficient HSPCs. a Scheme of experiment. b Lin− HSPCs isolated from WD-fed Apoe−/−Il27ra+/− (n = 4) and Apoe−/−Il27ra−/− (n = 4) mice infused with PBS or Apoe−/−Il27ra+/− (n = 5) and Apoe−/−Il27ra−/− (n = 4) mice infused with Ang II for 4 weeks were lysed and subjected to western blotting with p21, p53, and β-actin antibody. Each lane corresponds to individual mouse. c Quantification of WB analysis for p21 and p53, normalized to β-actin. d Scheme of experiment. e WB on Lin− HSPCs from naive Apoe−/−Il27ra+/− mice (n = 4) stimulated in vitro with Ang II, IL-27, or both for 24 h. f Quantification of WB analysis for p21. g Scheme of experiment. h Lin− HSPCs from BM of Apoe−/− (n = 4), Apoe−/−Il27ra−/− (n = 4), or Apoe−/−Il27ra−/−Trp53d/d (n = 5) mice were sorted and plated in M3434 media under myeloid conditions with or without Ang II. GM colony formation was accessed on day 6. Data are mean ± SEM from two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.005, unpaired Student’s t-test (two-tailed). i Scheme describing the role of IL-27R signaling in regulation of Ang II-induced myelopoiesis and AAA. Elevation of Ang II in AAA provides a stimulus for the activation of “stress” myelopoiesis via regulation of gene expression controlling proliferation and differentiation in IL-27R-sufficient LT-HSCs. Lack of IL-27R signaling renders Ang II-primed cells unable to overcome quiescence state and significantly reduces proliferation of progenitors and myeloid cell bone marrow output, therefore reducing cell accumulation in AAA lesions and AAA progression

false

  • Unconjugated

    Anti-beta Actin antibody [AC-15] - Loading Control

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

AC-15

Isotype

IgG1

Conjugation

HRP

Excitation/Emission
Carrier free

No

Reacts with

Hamster, Mouse, Rat, Cow, Dog, Human, African green monkey

Applications

WB

applications

Immunogen

Synthetic Peptide within Human ACTB aa 1-50 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P60709

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "African green monkey": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Cow": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Dictyostelium discoideum": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Dog": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Drosophila melanogaster": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" }, "Hamster": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/25000 - 1/50000", "WB-species-notes": "<p></p>" } } }

Product details

HRP Anti-beta Actin antibody [AC-15] (ab49900) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in WB in african green monkey, cow, dog, hamster, human, mouse, rat samples.

HRP Anti-beta Actin antibody [AC-15] (ab49900) has been cited over 457 times in peer reviewed journals and is trusted by the scientific community.

HRP Anti-beta Actin antibody [AC-15] (ab49900) has 10 independent reviews from customers.

HRP Anti-beta Actin antibody [AC-15] (ab49900) specifically detects beta Actin (UniProt ID: P60709; Molecular weight: 42kDa) and is sold in a 50 uL selling size.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.01% Thimerosal (merthiolate) Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta actin also known as beta cytoplasmic actin plays a central role in cell structure and motility. It is part of the actin protein family and is widely expressed in eukaryotic cells. The molecular weight of beta actin is approximately 42 kDa. It contributes to the formation of the cytoskeleton and participates in various cellular processes including movement and stability. Actin is abundant in all cell types providing structural integrity and flexibility.
Biological function summary

Beta actin contributes to the maintenance of cell shape and is an important player in cell division and muscle contraction. It forms part of a larger actin filaments network often associating with other proteins to form the actin cytoskeleton complex. This complex supports cellular processes such as signaling intracellular trafficking and positioning of organelles. The dynamic polymerization and depolymerization of actin filaments are critical for cellular functions.

Pathways

Beta actin functions in the regulation of important biological pathways such as the Rho/Rac/Cdc42 signaling pathway and the Wnt signaling pathway. These pathways are essential in numerous cellular activities including cell morphology and gene transcription. Beta actin closely interacts with proteins like myosin and tropomyosin which facilitate its role in muscle contraction and cell division and proteins such as Rac and Cdc42 which help govern cytoskeletal dynamics and cellular responses to extracellular stimuli.

Beta actin has links to cancers and muscular dystrophies. Aberrations in actin dynamics can result in tumor cell migration and metastasis making it a component of interest in cancer research. Additionally mutations or dysregulation in actin-associated proteins may contribute to muscular dystrophies affecting muscle function and strength. Beta actin's interactions with proteins like dystrophin involved in maintaining muscle integrity further highlight its relevance in both biological functions and disease contexts.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed : 25255767, PubMed : 29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed : 29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed : 29925947). Plays a role in the assembly of the gamma-tubulin ring complex (gTuRC), which regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments (PubMed : 39321809, PubMed : 38609661). Part of the ACTR1A/ACTB filament around which the dynactin complex is built (By similarity). The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity).
See full target information ACTB

Publications (592)

Recent publications for all applications. Explore the full list and refine your search

Molecular therapy. Oncology 33:201038 PubMed40984886

2025

Probing the metabolic regulator and candidate tumor suppressor ALDH1L1 as a target for non-small cell lung cancer gene therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Amira A Abdellatef,Blake R Rushing,Susan Sumner,Natalia I Krupenko,Sergey A Krupenko

Nature genetics 57:2177-2191 PubMed40858905

2025

ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L.

Applications

Unspecified application

Species

Unspecified reactive species

Weiran Feng,Erik Ladewig,Matthew Lange,Nazifa Salsabeel,Huiyong Zhao,Young Sun Lee,Anuradha Gopalan,Hanzhi Luo,Wenfei Kang,Ning Fan,Eric Rosiek,Elisa de Stanchina,Yu Chen,Brett S Carver,Christina S Leslie,Charles L Sawyers

Frontiers in oncology 15:1587236 PubMed40799237

2025

SHCBP1 drives tumor progression in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Huiling Wang,Huijuan Dai,Liheng Zhou,Yanping Lin,Wenjin Yin,Jingsong Lu

Molecules (Basel, Switzerland) 30: PubMed40733187

2025

The Role of Adenosine A1 and A2a Receptors in Cerebral Blood Vessel Reactivity of Sprague Dawley Rats Exposed to Hyperbaric Oxygenation.

Applications

Unspecified application

Species

Unspecified reactive species

Vedran Đambić,Zrinka Mihaljević,Ines Drenjančević,Ivana Jukić,Petar Šušnjara,Aleksandar Kibel

Translational cancer research 14:3822-3832 PubMed40687253

2025

Investigation of effects of CFI-400945 and ionizing radiation on DNA damage response in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Harjot Athwal,Vasudeva Bhat,Alison L Allan,Armen Parsyan

Frontiers in pharmacology 16:1601235 PubMed40641998

2025

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Lisanne Koll,Harm Jan Lourens,Glenn Marsman,Stan de Haan,Toshiro Niki,Gerwin A Huls,Edwin Bremer,Valerie R Wiersma

Cell reports 44:115962 PubMed40638391

2025

ANGPTL3 orchestrates hepatic fructose sensing and metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Zhao,Karen Y Linde-Garelli,Zeyuan Zhang,David Toomer,Saranya C Reghupaty,John Isaiah Jimenez,Laetitia Coassolo,Lianna W Wat,Daniel Fernandez,Katrin J Svensson

iScience 28:112748 PubMed40585507

2025

CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses.

Applications

Unspecified application

Species

Unspecified reactive species

Petros Kechagioglou,Hajime Yurugi,Camille Dupont,Alexey Chernobrovkin,Rossana Romero,Gregory Harms,Marie Oster,Sandra Ciesek,Rebecca Tweedell,Thirumala-Devi Kanneganti,Stefanie Zimmer,Stephen Cosenza,Steven M Fruchtman,Krishnaraj Rajalingam

Nucleic acids research 53: PubMed40586312

2025

ERH regulates type II interferon immune signaling through post-transcriptional regulation of JAK2 mRNA.

Applications

Unspecified application

Species

Unspecified reactive species

Adrian Soderholm,Milica Vunjak,Melanie de Almeida,Niko Popitsch,Nadezda Podvalnaya,Pablo Araguas-Rodriguez,Sara Scinicariello,Emily Nischwitz,Falk Butter,René F Ketting,Stefan L Ameres,Michaela Müller-McNicoll,Johannes Zuber,Gijs A Versteeg

Frontiers in immunology 16:1609165 PubMed40568595

2025

Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression.

Applications

Unspecified application

Species

Unspecified reactive species

Yongping Lai,Fei Wang,Guang Cai,Yingying Li,Jiaxin Weng,Feifan Cai,Leijie Cai,Niangmei Cheng,Bixing Zhao,Yongyi Zeng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com